GlobeImmune is developing vaccine candidates that target both Ras-mutated antigens and CEA antigens.
1 report, 1 independent
Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
GlobeImmune is developing vaccine candidates that target both Ras-mutated antigens and CEA antigens.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ras
Nothing else this week.
-
GlobeImmune
Nothing else this week.
-
Cea
municipality of Spain
Nothing else this week.